Glenmark Can't Nix Abbott's $16M Win Over Tarka Patent
A New Jersey federal judge on Friday rejected efforts by generic-drug maker Glenmark Pharmaceuticals Ltd. to overturn a jury's $16 million judgment against it for allegedly infringing a patent licensed exclusively...To view the full article, register now.
Already a subscriber? Click here to view full article